Chicago, IL, United States of America

Gregory R Thatcher

USPTO Granted Patents = 18 


 

Average Co-Inventor Count = 4.3

ph-index = 3

Forward Citations = 26(Granted Patents)


Location History:

  • Urbana, IL (US) (2018 - 2022)
  • Tucson, AZ (US) (2023)
  • Chicago, IL (US) (2016 - 2024)

Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: Gregory R. Thatcher: Innovator in Estrogen Receptor Research

Introduction: Gregory R. Thatcher is a prominent inventor based in Chicago, IL, with an impressive portfolio of 18 patents. His work primarily focuses on the development of innovative compounds that target estrogen receptors, showcasing his commitment to advancing medical science and treatment options.

Latest Patents: Some of Gregory's latest patents include:

1. **Substituted Benzothiophene Analogs as Selective Estrogen Receptor Degraders** - This patent relates to substituted benzothiophene analogs that function as selective degraders of the estrogen receptor. The invention outlines methods of synthesis, pharmaceutical compositions, and treatment methods for clinical conditions linked to estrogen receptors, such as breast cancer and osteoporosis.

2. **Benzothiophene-Based Selective Estrogen Receptor Downregulator Compounds** - This invention focuses on benzothiophene-based estrogen receptor downregulators, detailing their compositions and applications for treating estrogen-related medical disorders.

Career Highlights: Gregory has had a distinguished career, with significant contributions made during his tenure at institutions such as the University of Illinois and G1 Therapeutics, Inc. His innovative research and dedication to addressing critical health issues have made a lasting impact in the field of pharmacology.

Collaborations: Throughout his career, Gregory has collaborated with notable colleagues, including Rui Xiong and Jiong Zhao. These partnerships have played a pivotal role in enhancing the creativity and effectiveness of his research endeavors.

Conclusion: Gregory R. Thatcher is a key figure in the biotechnology sector, particularly in the area of estrogen receptor modulation. With his extensive patent portfolio and collaborative efforts, he continues to push the boundaries of science, contributing to the development of vital treatments for estrogen-related conditions. His work not only exemplifies innovation but also highlights the importance of medical research in improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…